Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 15/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | STS | P08842 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | FLT1 | P17948 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7657427 | 0.78 | FLT3 (0.31) | — | |
| SCHEMBL7654440 | 0.78 | CYP19A1 (0.56) | CYP19A1HDAC1HDAC6STS | |
| SCHEMBL7654639 | 0.73 | CYP19A1 (0.42) | CYP19A1HDAC1HDAC6 | |
| SCHEMBL6693307 | 0.69 | CYP19A1 (0.61) | CYP19A1HDAC1HDAC6 | |
| SCHEMBL8300516 | 0.68 | ACHE (0.31) | — | |
| SCHEMBL7674570 | 0.68 | CYP19A1 (0.79) | CYP19A1HDAC1HDAC6STS | |
| SCHEMBL15688800 | 0.67 | CYP19A1 (0.71) | CYP19A1HDAC1HDAC6STS | |
| SCHEMBL8300436 | 0.66 | ACHE (0.31) | — | |
| SCHEMBL6700110 | 0.66 | CYP19A1 (0.56) | CYP19A1HDAC1HDAC6KDR | |
| SCHEMBL7655658 | 0.66 | CYP19A1 (0.75) | CYP19A1STS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6358984-B1 | FOR THERAPY OF HYPERTENSION AND/OR DISEASES SUCH AS HEART AND RENAL DISEASES | LEAD CHEMICAL CO., LTD. (JP) | 2002-03-19 | — | — | US | disclosed |
| US-6232335-B1 | A BIPHENYL TRIAZOLE COMPOUND USEFUL AS A ANGIOTENSIN II CONVERTING ENZYME INHIBITORS EFFECTIVE IN THE TREATMENT OF HYPERTENSION OR HEART FAILURE | LEAD CHEMICAL CO., LTD. (JP) | 2001-05-15 | — | — | US | disclosed |